Proliferating cell nuclear antigen as the cell cycle sensor for an HLA- derived peptide blocking T cell proliferation

Journal of Immunology

Volumn 164, Issue 12, 2000, Pages 6188-6192

  Ling, Xuefeng ^a   Kamangar, Salar ^a   Boytim, Michelle L ^a   Kelman, Zvi ^c   Huie, Philip ^b   Lyu, Shu Chen ^a   Sibley, Richard K ^b   Hurwitz, Jerard ^c   Clayberger, Carol ^a   Krensky, Alan M ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; CYCLINE; HLA ANTIGEN;

ARTICLE; CELL CYCLE G1 PHASE; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; RETINOBLASTOMA; T LYMPHOCYTE;

EID: 0034659910     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.12.6188     Document Type: Article

References (21)

1. Clayberger, C., P. Parham, J. Rothbard, D. S. Ludwig, G. K. Schoolnik, and A. M. Krensky. 1987. HLA-A2 peptides can regulate cytolysis by human allogeneic T lymphocytes. Nature 330:763.
2. Parham, P., C. Clayberger, S. L. Zorn, D. S. Ludwig, G. K. Schoolnik, and A. M. Krensky. 1987. Inhibition of alloreactive cytoloxic T lymphocytes by peptides from the α2 domain of HLA-A2. Nature 325:625.
3. Nisco, S., P. Vriens, O. Hoyt, S. C. Lyu, F. Farfan, P. Pouletty, A. M. Krensky, and C. Clayberger. 1994. Induction of allograft tolerance in rats by an HLA class-I-derived peptide and cyclosporine A. J. Immunol. 152:3786.
4. Noessner, E., J. Goldberg, C. Naftzger, S.-C. Lyu, C. Clayberger, and A. Krensky. 1996. HLA-derived peptides which inhibit T cell function bind to members of the heat-shock protein 70 family. J. Exp. Med. 183:339.
5. Giral, M., M. C. Cuturi, J. M. Nguyen, R. Josien, J. Dantal, R. Floc'h, R. Buelow, P. Pouletty, and J. P. Soulillou. 1997. Decreased cytotoxic activity of natural killer cells in kidney allograft recipients treated with human HLA-derived peptide. Transplantation 63:1004.
6. Boytim, M. L., S. C. Lyu, R. Jung, A. M. Krensky, and C. Clayberger. 1998. Inhibition of cell cycle progression by a synthetic peptide corresponding to residues 65-79 of an HLA class 11 sequence: functional similarities but mechanistic differences with the immunosuppressive drug rapamycin. J. Immunol. 160:2215.
7. cip on DNA synthesis catalyzed by the human and Saccharomyces cerevisiae poymerase δ holoenzyme. J. Biol. Chem, 272:2373.
8. Fields, S., and O. Song. 1989. A novel genetic system to detect protein-protein interactions. Nature 340:245.
9. Kelman, Z. 1997. PCNA: structure, functions and interactions. Oncogene 14:629.
10. Loor, G., S. J. Zhang, P. Zhang, N. L. Toomey, and M. Y. Lee. 1997. Identification of DNA replication and cell cycle proteins that interact with PCNA. Nucleic Acids Res. 25:5041.
11. Bambara, R. A., R. S. Murante, and L. A. Henricksen. 1997. Enzymes and reactions at the eukaryotic DNA replication fork. J. Biol. Chem. 272:4647.
12. Chen, J., R. Peters, P. Saha, P. Lee, A. Theodoras, M. Pagano, G. Wagner, and A. Dutta. 1996. A 39 amino acid fragment of the cell cycle regulator p21 is sufficient to bind PCNA and partially inhibit DNA replication in vivo. Nucleic Acids Res. 24:1727.
13. Xiong, Y., H. Zhang, and D. Beach. 1992. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71:505.
14. Xiong, Y., H. Zhang, and D. Beach. 1993. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev. 7:1572.
15. Zhang, H., Y. Xiong, and D. Beach. 1993. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol. Biol. Cell 4:897.
16. Ogryzko, V. V., P. Wong, and B. H. Howard. 1997. WAF1 retards S-phase progression primarily by inhibition of cyclin-dependent kinases. Mol. Cell. Biol. 17:4877.
17. Pagano, M., A. M. Theodoras, S, W. Tam, and G. F. Draetta. 1994. Cyclin D1-mediated inhibition of repair and replicalive DNA synthesis in human fibroblasts. Genes Dev. 8:1627.
18. 1 phase integrators of the mitogenic response. Cold Spring Harbor Symp. Quant. Biol. 59:11.
19. Matsuoka, S., M. Yamaguchi, and A. Matsukage. 1994. D-type cyclin-binding regions of proliferating cell nuclear antigen. J. Biol. Chem. 269:11030.
20. Abraham, R. T., and G. J. Wiederrecht. 1996. Immunopharmacology of rapamycin. Annu. Rev. Immunol. 14:483.
21. Feuerstein, N., D. Huang, and M. B. Prystowsky. 1995. Rapamycin selectively blocks interleukin-2-induced proliferating cell nuclear antigen gene expression in T lymphocyte: evidence for inhibition of CREB/ATF binding activities. J. Biol. Chem. 270:9454.